Weiss Gold Veteran Makes Shocking New Call
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Analysts See Big Upside For Newly Listed Molecular Diagnostic Firm BillionToOne After Standout IPO Rally
Analysts launch bullish coverage on BillionToOne as its IPO surge, prenatal growth, and molecular diagnostics platform drive optimism.
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.
Trump Just Signed s.1582 Into Law - Now the Countdown Begins... - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on December 18. Investors who make the right moves before then could make up to 40X by 2032...
Why Is Scholar Rock Holding Stock Climbing Today?
Scholar Rock shares jump after the company strengthened its cash runway into 2027 and advanced launch preparations for its lead drug candidate, apitegromab.
Evommune's Skin Disorder Candidate Has 'Blockbuster Commercial Opportunity': Analyst Projects $5 Billion Peak Sales
Evommune gains an Outperform rating as William Blair cites strong EVO756 trial data and blockbuster sales potential.
Cyber Weekend Sale! 85% Off Disruptors and Dominators! - Ad
Nvidia's robot breakthrough, unveiled by CEO Jensen Huang at CES, could spark a $24T revolution. He said the "ChatGPT moment" for robotics is near. I believe the lives of 65M Americans could be impacted - this year. And one $7 stock could be the biggest winner.
New FDA-approved glasses can slow nearsightedness in kids
WASHINGTON (AP) — For many children, the experience of getting their first pair of glasses is an inevitable milestone, the first in a lifetime of visits to the eye doctor.
Biogen, Eisai File In Japan To Make Leqembi A Weekly At-Home Alzheimer's Shot
Eisai files for Japan approval of a weekly at-home Leqembi injection, offering an alternative to IV dosing and aiming to streamline Alzheimer's care.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Baxter Warns Of Potential Device Tampering In Life2000 Ventilator Recall
Baxter recalls its Life2000 ventilators after a cybersecurity flaw prompts an FDA high-risk alert, urging patients to stop use and seek replacement options.
BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review
BiomX works to address FDA device questions as a safety panel supports the BX004 trial, with topline results now expected in Q2 2026.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe
Sanofi faces a surprise tax probe in France as Dupixent secures EU approval for treating chronic spontaneous urticaria.
Novo Nordisk Alzheimer's Miss Disappointing But Not Material, Analyst Says
Novo Nordisk stock falls after disappointing results from Alzheimer's trial. Analysts remain cautious about future growth prospects.
First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad
This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Bayer's asundexian cut ischemic stroke risk without more bleeding, boosting FXIa optimism while raising fresh questions for Bristol Myers' milvexian program.
Here's what's next in the fight to curb climate change, now that talks in Brazil have ended
BELEM, Brazil (AP) — After from U.N. climate talks in the Amazon that fell short of many nations' expectations, experts found some bright spots alongside weighty reasons for worry in the fight against .
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Plan for $20 million firefighter training center near the site of Ohio derailment revived
Norfolk Southern railroad worked with the state of Ohio and Youngstown State University to revive plans for a $20 million first responder training center near the site of the in East Palestine, Ohio.
FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder
FDA reports rare neutralizing antibodies, including a pediatric death, in patients treated with Takeda's Adzynma for congenital TTP.
The Smart Money Copper Trade - Ad
Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Vanda's tradipitant cut Wegovy-related vomiting by 50% in a new trial, prompting bullish analyst views and price targets.
Activist Investor Drops Scathing Letter, Slams Cooper's 'Growth At All Costs' Approach
Browning West urges changes for underperforming Cooper Companies, highlighting weak oversight and misaligned incentives.
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the on some store shelves.
Guterres and Lula to push negotiators at COP30 as deadline looms
BELEM, Brazil (AP) — Two global power players will spend Wednesday pushing negotiators to find compromises at in Brazil’s Belém, where a self-imposed deadline is rushing up fast.
Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad
Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.
Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer
Genmab's Epkinly receives traditional FDA approval for relapsed or refractory follicular lymphoma in combination and monotherapy. Clinical trial data show superior results.
Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers
A U.S. Bankruptcy Court judge is set to give his reasoning Tuesday for approving OxyContin maker Purdue Pharma's plan to settle thousands of lawsuits over the toll of opioids.
85% Off: Unlock the 5 gold stocks that could surge - Ad
Gold pushed past $4,200, but our expert Sean Brodrick says the real opportunity could lie in a handful of stocks that may soar far beyond gold. He believes the biggest bull market is taking shape and thinks these five companies may have major upside. This weekend only, you can get all five names for just $19.
AP Lifestyles Digest for week of Nov. 17
Here is the AP Lifestyles Digest for the week of Nov. 17. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.
Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
A judge said Friday that he planned to approve a deal and members of the Sackler family who own the company to settle thousands of lawsuits over the toll of opioids, allowing money to start flowing to victims as soon as next spring.
Trump Just Signed s.1582 Into Law - Now the Countdown Begins... - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on December 18. Investors who make the right moves before then could make up to 40X by 2032...
Climate leaders are talking about 'overshoot' into warming danger zone. Here's what it means
BELEM, Brazil (AP) — The world's climate leaders are conceding that will shoot past a hard limit they set a decade ago in hopes of keeping the planet out of a danger zone. But they're not conceding defeat.
Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
Doritos and Cheetos are getting a makeover.
Cyber Weekend Sale! 85% Off Disruptors and Dominators! - Ad
Nvidia's robot breakthrough, unveiled by CEO Jensen Huang at CES, could spark a $24T revolution. He said the "ChatGPT moment" for robotics is near. I believe the lives of 65M Americans could be impacted - this year. And one $7 stock could be the biggest winner.
UK commits to ensuring 'poignant' COVID memorial wall in London will be preserved
LONDON (AP) — The British government said Thursday that a memorial wall in London created by those who lost loved ones during the coronavirus pandemic will be preserved.
Zanzibar’s ‘solar mamas’ are trained as technicians to help light up communities
ZANZIBAR, Tanzania (AP) — When darkness came, so did the smoke.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.